Advertisement

The Sclera pp 242-277 | Cite as

Infectious Scleritis: The Massachusetts Eye and Ear Infirmary Experience

  • C. Stephen Foster
  • Maite Sainz de la Maza

Abstract

Although systemic immune-mediated diseases are the main possibilities in the differential diagnosis of scleritis, other unusual etiologies such as infectious diseases must also be con-sidered. Infectious scleritis, either endogenous or exogenous, may be caused either by a direct invasion of organisms that cause the systemic and local signs, or by an immune response induced by the infectious agent.

Keywords

Herpes Zoster Lyme Disease Postherpetic Neuralgia Oral Acyclovir Acanthamoeba Keratitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Reynolds MG, Alfonso E: Infectious scleritis and keratoscleritis: management and outcome. Am J Ophthalmol 112: 543, 1991.PubMedGoogle Scholar
  2. 2.
    Alfonso E, Kenyon KR, Ormerod LD, Stevens R, Wagoner MD, Albert DM: Pseudomonas corneoscleritis. Am J Ophthalmol 103: 90, 1987.PubMedGoogle Scholar
  3. 3.
    Codere F, Brownstein S, Jackson WB: Pseu-domonas aeruginosa scleritis. Am J Oph-thalmol 91: 706, 1981.Google Scholar
  4. 4.
    Raber IM, Laibson PR, Kurz GH, Bernardino VB: Pseudomonas corneoscleral ulcers. Am J Ophthalmol 92: 353, 1981.PubMedGoogle Scholar
  5. 5.
    Eiferman RA: Cryotherapy of Pseudomonas keratitis and scleritis. Arch Ophthalmol 97: 1637, 1979.PubMedGoogle Scholar
  6. 6.
    Nanda M, Pflugfelder SC, Holland S: Ful-minant pseudomonal keratitis and scleritis in human immunodeficiency virus-infected patients. Arch Ophthalmol 109: 503, 1991.PubMedGoogle Scholar
  7. 7.
    Farrell PLR, Smith RE: Bacterial corneoscle-ritis complicating pterygium excision. Am J Ophthalmol 107: 515, 1989.PubMedGoogle Scholar
  8. 8.
    Cameron ME: Preventable complications of pterygium excision with beta-irradiation. Br J Ophthalmol 56: 52, 1972.PubMedGoogle Scholar
  9. 9.
    Tarr KH, Constable IJ: Late complications of pterygium treatment. Br J Ophthalmol 64:496Google Scholar
  10. 10.
    Tarr KH, Constable IJ: Pseudomonas endo-phthalmitis associated with scleral necrosis. Br J Ophthalmol 64: 676, 1980.PubMedGoogle Scholar
  11. 11.
    Tarr KH, Constable IJ: Radiation damage after pterygium treatment. Aust J Ophthalmol 9:97Google Scholar
  12. 12.
    Berler DK, Alper MG: Scleral abscesses and ectasia cased by Pseudomonas aeruginosa. Ann Ophthalmol 14: 665, 1982.PubMedGoogle Scholar
  13. 13.
    Altman AJ, Cohen EJ, Berger ST, Mondino BJ: Scleritis and Streptococcus pneumoniae. Cornea 10 (4): 341, 1991.PubMedGoogle Scholar
  14. 14.
    Sainz de la Maza M, Foster CS: Necrotizing scleritis after ocular surgery. Ophthalmology 98: 1720, 1991.Google Scholar
  15. 15.
    Duke-Elder S: System of Ophthalmology, Vol 3. Kimpton, London, 1964, p 825.Google Scholar
  16. 16.
    Zinn KM, Ferry AP: Massive scleral necrosis from a Pseudomonas infection following scleral buckling and pars plana vitrectomy surgery. Mt Sinai J Med 47: 618, 1980.PubMedGoogle Scholar
  17. 17.
    Watson P: Diseases of the sclera and epi-sclera. In DuaneTD, Jaeger EA (Eds): Clinical Ophthalmology, Vol 4. Harper & Row, Philadelphia, 1985, Chap 23.Google Scholar
  18. 18.
    Jackson WB: Infections of the sclera. In Tab-bara KF, Hyndiuk RA (Eds): Infections of the Eye. Little, Brown, Boston, 1986, Chap 28.Google Scholar
  19. 19.
    Friedman AH, Henkind P: Unusual cases of episcleritis. Trans Am Acad Ophthalmol Otolaryngol 78: 890, 1974.Google Scholar
  20. 20.
    Harbin T: Recurrence of a corneal pseudo-monal infection. Am J Ophthalmol 58: 670, 1964.PubMedGoogle Scholar
  21. 21.
    Alpren TVP, Hyndiuk RA, Davis SD, Starff LD: Cryotherapy for experimental Pseudo-monas keratitis. Arch Ophthalmol 97: 711, 1979.PubMedGoogle Scholar
  22. 22.
    Turner L, Stinson I: Mycobacterium fortuitum as a cause of corneal ulcer. Am J Ophthalmol 60: 329, 1965.PubMedGoogle Scholar
  23. 23.
    Zimmerman LE, Turner L, McTigue JW: Mycobacterium fortuitum infection of the cor-nea. Arch Ophthalmol 82: 596, 1969.PubMedGoogle Scholar
  24. 24.
    Gangadharam PR J, Lanier JD, Jones DE: Keratitis due to Mycobacterium chelonei. Tubercle 59: 55, 1978.PubMedGoogle Scholar
  25. 25.
    Newman PE, Goodman RA, Waring GO III, Finton RJ, Wilson LA, Wrigh TJ, Cavanagh HD: A cluster of cases of Mycobacterium chelonei keratitis associated with outpatient office procedures. Am J Ophthalmol 97: 344, 1984.PubMedGoogle Scholar
  26. 26.
    Moore MB, Newton C, Kaufman HE: Chronic keratitis caused by Mycobacterium gordonae. Am J Ophthalmol 102: 516, 1986.PubMedGoogle Scholar
  27. 27.
    Laflamme MY, Poisson M, Chehade N: Mycobacterium chelonei keratitis following penetrating keratoplasty. Can J Ophthalmol 22: 178, 1987.PubMedGoogle Scholar
  28. 28.
    Pope J, Sternberg P, McLane NJ, Potts DW, Stulting RD: Mycobacterium chelonei scleral abcess after removal of a scleral buckle. Am J Ophthalmol 107: 557, 1989.PubMedGoogle Scholar
  29. 29.
    Schonherr U, Naumann GOH, Lang GK, Bialasiewicz AA: Sclerokeratitis by Mycobac-terium marinum. Am J Ophthalmol 108: 607, 1989.PubMedGoogle Scholar
  30. 30.
    Carson LA, Peterson NJ, Favero MS, Aguero SM. Growth characteristics of atypical myco-bacteria in water and their comparative resis-tance to disinfectants. Appl Environ Microbiol 36: 839, 1978.PubMedGoogle Scholar
  31. 31.
    Jolly HW, Seabury JH: Infections with Myco-bacterium marinum. Arch Dermatol 106: 32, 1972.PubMedGoogle Scholar
  32. 32.
    Zeligman I: Mycobacterium marinum granu-loma. Arch Dermatol 106:26, 1972.Google Scholar
  33. 33.
    Spencer WH: Ophthalmic Pathology. An Atlas and Textbook, 3rd ed. W.B. Saunders, Phila-delphia, 1985, pp 275–277.Google Scholar
  34. 34.
    Kubica GP: Differential identification of myco-bacteria. VII. Key features for identification of clinically significant mycobacteria. Am Rev lesp Dis 107: 9, 1973.Google Scholar
  35. 35.
    Wolinsky E: Nontuberculous mycobacterial in-fections of man. Med Clin N Am 58: 639, 1974.PubMedGoogle Scholar
  36. 36.
    Donahue HC: Ophthalmologic experience in a tuberculosis sanatorium. Am J Ophthalmol 64: 742, 1967.PubMedGoogle Scholar
  37. 37.
    Watson PG, Hayreh SS: Scleritis and episcle-ritis. Br J Ophthalmol 60: 163, 1976.PubMedGoogle Scholar
  38. 38.
    Nanda M, Pflugfelder SC, Holland S: Myco-bacterium tuberculosis scleritis. Am J Oph-thalmol 108: 736, 1989.Google Scholar
  39. 39.
    Glassroth J, Robins AG, Snider DE Jr: Tuber-culosis in the 1980’s. N Engl J Med 302: 1441, 1980.PubMedGoogle Scholar
  40. 40.
    Shumomura Y, Tader R, Yuam T: Ocular disorders in pulmonary tuberculosis. Folia Ophthalmol Jpn 30: 1973, 1979.Google Scholar
  41. 41.
    Phillips S, Williams ML, Maiden SD: Chronic miliary tuberculosis. Am Rev Tuberculosis 62: 549, 1950.Google Scholar
  42. 42.
    Bloomfield SE, Mondino B, Gray GF: Scleral tuberculosis. Arch Ophthalmol 94: 954, 1976.PubMedGoogle Scholar
  43. 43.
    Bell GH: Report of a case of tuberculosis of the sclera of probable primary origin. Trans Am Ophthalmol Soc 13: 787, 1914.PubMedGoogle Scholar
  44. 44.
    Swan KC: Some contemporary concepts of scleral disease. Arch Ophthalmol 45: 630, 1951.Google Scholar
  45. 45.
    Finnoff WC: Tuberculosis in etiology of acute iritis. Am J Ophthalmol 14: 127, 1931.Google Scholar
  46. 46.
    Brini A, Quere M, Achard M: Sclerite no-dulaire necrosante (presence de bacille de Koch). Bull Soc Ophthalmol Fr 7: 822, 1953.Google Scholar
  47. 47.
    Andreani DG: Tuberculoma of the sclera. Giornale Italiano di Oftalmologia 7: 506, 1954.Google Scholar
  48. 48.
    Woods AC: Ocular tuberculosis. In Sorsby A (Ed): Modern Ophthalmology. Lippincott, Philadelphia, 1972, p 105.Google Scholar
  49. 49.
    Sarda RP, Mehrotra AS, Asnani K: Nodular episcleritis (a proved case of tubercular origin). Indian J Ocular Pathol 3: 24, 1969.Google Scholar
  50. 50.
    Thygeson PL: The etiology and treatment of phlyctenular keratoconjunctivitis. Am J Oph-thalmol 9: 446, 1975.Google Scholar
  51. 51.
    Smith RE, Dippe DW, Miller SD: Phlyctenular keratoconjunctivitis. Results of penetrating keratoplasty in Alaskan natives. Ophthalmic Surg 6: 62, 1975.Google Scholar
  52. 52.
    Shepard CC: The experimental disease that follows the injection of human leprosy bacilli into footpads of mice. J Exp Med 112: 445, 1960.PubMedGoogle Scholar
  53. 53.
    Bechelli LM, Dominguez UM: The leprosy problem in the world. Bull WHO 34: 811, 1966.PubMedGoogle Scholar
  54. 54.
    Shepard CC: Leprosy. In Harrison TR (Ed): Principles of Internal Medicine, McGraw-Hill, New York, 1980, pp 711–714.Google Scholar
  55. 55.
    Memoria del VI Congreso Internacional de Leprologia, Madrid, October 1953.Google Scholar
  56. 56.
    Van Voorhis WC, Kaplan G, Sarno EN, Horwitz MA, Steinman RM, Levis WR, Nogueira N, Hair LS, Gattass, Arrick BA, Cohn ZA: The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T- cell phenotypes. N Engl J Med 307: 1593, 1982.PubMedGoogle Scholar
  57. 57.
    De Barros JM: Aspectos clinicos do comproli-mento ocular da lepra. Companhia Melhora-mentos, Sao Paulo, 1939.Google Scholar
  58. 58.
    Brand ME: Early ocular changes in leprosy. IXth International Leprosy Conference, London, 1968.Google Scholar
  59. 59.
    Schwab IR: Ocular leprosy. In Tabbara JF, Hyndiuk RA (Eds): Infections of the Eye. Little, Brown, Boston, 1986, pp 613–624.Google Scholar
  60. 60.
    King EF: Eye in leprosy. Br J Ophthalmol 20: 561, 1936.Google Scholar
  61. 61.
    Allen JH, Byers JL: The pathology of ocular leprosy. Arch Ophthalmol 64: 216, 1960.PubMedGoogle Scholar
  62. 62.
    Ffytche TJ: Role of iris changes as a cause of blindness in lepromatous leprosy. Br J Oph-thalmol 65: 231, 1981.Google Scholar
  63. 63.
    Holmes, KK, Lukehart SA: Syphilis. In Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fanci AS (Eds): Har-rison’s Principles of Internal Medicine, 11th ed, Vol 1. McGraw-Hill, New York, 1987, pp 639–649.Google Scholar
  64. 64.
    Centers for Disease Control: Summary-cases of specified notifiable diseases, United States. MMWR 37: 802, 1989.Google Scholar
  65. 65.
    Tamesis RR, Foster CS: Ocular syphilis. Oph-thalmology 97: 1281, 1990.Google Scholar
  66. 66.
    Johns DR, Tierney M, Felsenstein D: Alter-ation in the natural history of neurosyphilis by concurrent infection with the human immuno-deficiency virus. N Engl J Med 316: 1569, 1987.PubMedGoogle Scholar
  67. 67.
    Berry CD, Hooton TM, Collier AC, Lukehart SA: Neurologic relapse after benzathine peni-cillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 316: 1587, 1987.PubMedGoogle Scholar
  68. 68.
    Richards BW, Hessburg TJ, Nussbaum JN: Recurrent syphilitic uveitis. N Engl J Med 320: 62, 1989.PubMedGoogle Scholar
  69. 69.
    Levy JH, Liss RA, Maguire AM: Neurosyphilis and ocular syphilis in patients with concurrent human immunodeficient virus infection. Retina 9: 175, 1989.PubMedGoogle Scholar
  70. 70.
    Zaidman GW: Neurosyphilis and retrobulbar neuritis in a patient with AIDS. Ann Oph-thalmol 18: 260, 1986.Google Scholar
  71. 71.
    Carter JB, Hamill RJ, Matoba AY: Bilateral syphilitic optic neuritis in a patient with a posi-tive test for HIV. Arch Ophthalmol 105: 1485, 1987.PubMedGoogle Scholar
  72. 72.
    Kleiner RC, Najarian L, Levenson J, Kaplan HJ: AIDS complicated by syphilis can mimick uveitis and Crohn’s disease [Letter]. Arch Oph-thalmol 105: 1486, 1987.Google Scholar
  73. 73.
    Zambrano W, Perez GM, Smith JL: Acute syphilitic blindness in AIDS. J Clin Neurol Ophthalmol 7: 1, 1987.Google Scholar
  74. 74.
    Stoumbos VD, Klein ML: Syphilitic retinitis in a patient with acquired immunodeficiency syndrome-related complex [Letter]. Am J Ophthalmol 103: 103, 1987.PubMedGoogle Scholar
  75. 75.
    Radolf JD, Kaplan RP: Unusual manifes-tations of secondary syphilis and abnormal humoral immune response to Treponema pallidum antigens in a homosexual man with asymptomatic human immunodeficiency virus infection. J Am Acad Dermatol 18: 423, 1988.PubMedGoogle Scholar
  76. 76.
    Passo MS, Rosembaum JT: Ocular syphilis in patients with human immunodeficiency virus infection. Am J Ophthalmol 106: 1, 1988.PubMedGoogle Scholar
  77. 77.
    Wilhelmus KR: Syphilis. In Insler MS (Ed): AIDS and Other Sexually Transmitted Diseases and the Eye. Grune & Stratton, Orlando, FL, 1987, pp 73–104.Google Scholar
  78. 78.
    Wilhelmus KR, Yokoyama CM: Syphilitic epi-scleritis and scleritis. Am J Ophthalmol 104: 595, 1987.PubMedGoogle Scholar
  79. 79.
    Evans JJ: Diffuse gummatous infiltration of scleral and episcleral tissues. Trans Oph-thalmol Soc UK 25: 188, 1905.Google Scholar
  80. 80.
    Watson PG, Hazleman BL: The Sclera and Systemic Disorders. W.B. Saunders, Phila-delphia, 1976, pp 206–346.Google Scholar
  81. 81.
    Deodati F, Bee P, Labro JB, Barrioulet Y: Sclerite syphilitique. Aspect clinique et angi-ographique. Bull Soc Ophtalmol Fr 71: 63, 1971.PubMedGoogle Scholar
  82. 82.
    Spicer WTH: Parenchymatous keratitis; inter-stitial keratitis; uveitis anterior. Br J Oph-thalmol (Monogr Suppl I) 1, 1924.Google Scholar
  83. 83.
    Yobs AR, Brown, L, Hunter EF: Fluorescent antibody technique in early syphilis. Arch Pathol 77: 220, 1964.PubMedGoogle Scholar
  84. 84.
    Tourville DR, Byrd LH, Kim DU, Zajd D, Lee I, Reichman LB, Baskin S: Treponemal antigen in immunopathogenesis of syphilitic glomerulonephritis. Am J Pathol 82: 479, 1976.PubMedGoogle Scholar
  85. 85.
    Bansal RC, Cohn H, Fani K, Lynfield YL: Nephrotic syndrome and granulomatous hepa-titis. Arch Dermatol 114: 1228, 1978.PubMedGoogle Scholar
  86. 86.
    Beckett JH, Bigbee JW: Immunoperoxidase localization of Treponema pallidum. Arch Pathol 103: 135, 1979.Google Scholar
  87. 87.
    Trantas M: Bourrelet perikeratique syphi-litique. Arch Ophtalmol (Paris) 31: 320, 1911.Google Scholar
  88. 88.
    Bhaduri BN, Basu SK: Scleral gumma. Br J Ophthalmol 40: 504, 1956.Google Scholar
  89. 89.
    Spoor TC, Wynn P, Hartel WC, Bryan CS: Ocular syphilis: acute and chronic. J Clin Neurol Ophthalmol 3: 197, 1983.Google Scholar
  90. 90.
    Harner RE, Smith JL, Israel CW: The FTA- ABS in late syphilis. A serological study in 1985 cases. JAMA 203: 545, 1968.PubMedGoogle Scholar
  91. 91.
    Hart G: Syphilis tests in diagnostic and ther-apeutic decision making. Ann Intern Med 104: 368, 1986.PubMedGoogle Scholar
  92. 92.
    Collart P, Poitevin M: Is penicillin therapy always infallible in syphilis? J Clin Neurol Oph-thalmol 2: 77, 1982.Google Scholar
  93. 93.
    Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM: Lyme arthritis: an epidemic of oligoarti-cular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 20: 7, 1977.PubMedGoogle Scholar
  94. 94.
    Steere AC, Taylor E, Wilson ML, Levine JF, Spielman A: Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. J Infect Dis 154: 295, 1986.PubMedGoogle Scholar
  95. 95.
    Hanrahan JP, Benach JL, Coleman JL, Bosler EM, Morse DL, Cameron DJ, Edelman R, Kaslow RA: Incidence and cumulative fre-quency of endemic Lyme disease in a com-munity. J Infect Dis 150: 489, 1984.PubMedGoogle Scholar
  96. 96.
    MacDonald AB: Lyme disease: a neuro-ophthalmologic view. J Clin Neurol Oph-thalmol 7: 185, 1987.Google Scholar
  97. 97.
    Steere AC, Malawista SE: Cases of Lyme dis-ease in the United States, locations correlated with the distribution of Ixodes dammini. Ann Intern Med 91: 730, 1979.PubMedGoogle Scholar
  98. 98.
    Burgdorfer W, Keirans JE: Ticks and Lyme disease in the United States. Ann Intern Med 99: 121, 1983.PubMedGoogle Scholar
  99. 99.
    Steere AC, Broderick TE, Malawista SE: Ery-thema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Am J Epidemiol 108: 312, 1978.PubMedGoogle Scholar
  100. 100.
    Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP: Lyme disease—a tick-borne spirochetosis? Science 216: 1317, 1982.PubMedGoogle Scholar
  101. 101.
    Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbour AG, Burgdofer W, Schmid GP, Johnson E, Malawista SE: The spirochetal etiology of Lyme disease. N Engl J Med 308: 740, 1983.Google Scholar
  102. 102.
    Benach JL, Bosler EM, Hanrahan JP, Coleman JL, Habicht GS, Bast TF, Cameron DJ, Ziegler JL, Barbour AG, Burgdorfer W, Edelman R, Kaslow RA: Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 308: 740, 1983.PubMedGoogle Scholar
  103. 103.
    Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase PW, Andiman WA: Erythema chronicum migrans and Lyme arthritis: the enlarging clinical spectrum. Ann Intern Med 86: 685, 1977.PubMedGoogle Scholar
  104. 104.
    Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW, Sigal LH, Spieler PN, Stenn KS, Malawista SE: The early clinical manifestations of Lyme disease. Ann Intern Med 99: 76, 1983.PubMedGoogle Scholar
  105. 105.
    Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE: Neurologic abnormalities of Lyme disease. Medicine 58: 281, 1979.PubMedGoogle Scholar
  106. 106.
    Steere AC, Batsford WP, Weinberg M, Al-exander J, Berger HJ, Wolfson S, Malawista SE: Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med 93: 8, 1980.PubMedGoogle Scholar
  107. 107.
    Halperin JJ, Pass HL, Anand AK, Luft BJ, Valkman DJ, Dattwyler RJ: Nervous system abnormalities in Lyme disease. Ann NY Acad Sci 539: 24, 1988.PubMedGoogle Scholar
  108. 108.
    Schmutzhard E, Pohl P, Stockhammer G, et al.\ Unusual neurological manifestations of second-stage Lyme borreliosis. Ann NY Acad Sci 539: 495, 1988.Google Scholar
  109. 109.
    Schmutzhard E, Pohl P, Stanek G: Involve-ment of Borrelia burgdorferi in cranial nerve affection. Zentralbl Bakteriol Mikrobiol Hyg 263: 328, 1986.Google Scholar
  110. 110.
    Wallis RC, Brown SE, Kloter KO, Main AJ Jr: Erythema chronicum migrans and Lyme arthritis: field study of ticks. Am J Epidemiol 108: 322, 1978.PubMedGoogle Scholar
  111. 111.
    Steere AC, Gibofsky A, Patarroyo ME, Winchester RJ, Hardin JA, Malawista SE: Chronic Lyme arthritis: clinical and immuno-genetic differentiation from rheumatoid ar-thritis. Ann Intern Med 90: 896, 1979.PubMedGoogle Scholar
  112. 112.
    Steere AC, Brinckerhoff CE, Miller DJ, Drinker H, Harris ED Jr, Malawista SE: Ele-vated levels of collagenase and prostaglandin E2 from synovium associated with erosion of cartilage and bone in a patient with chronic Lyme arthritis. Arthritis Rheum 23: 591, 1980.PubMedGoogle Scholar
  113. 113.
    Pachner AR, Steere AC: CNS manifes-tations of third stage Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg 263: 301, 1986.Google Scholar
  114. 114.
    Stiernstedt G, Gustafsson R, Karlsson M, Svenungsson B, Skoldenberg B: Clinical mani-festations and diagnosis of neuroborreliosis. Ann NY Acad Sci 539: 46, 1988.PubMedGoogle Scholar
  115. 115.
    Kristoferitsch W, Sluga E, Graf M, Partsch H, Neumann R, Stanek G, Budka H: Neuropathy associated with acrodermatitis chronica atrophi-cans. Ann NY Acad Sci 539: 35, 1988.PubMedGoogle Scholar
  116. 116.
    Ackermann R, Rehse-Kiipper B, Gollmer E, Schmidt R: Chronic neurologic manifestations of erythema migrans borreliosis. Ann NY Acad Sci 539: 16, 1988.PubMedGoogle Scholar
  117. 117.
    Pachner AR, Duray P, Steere AC: Central nervous system manifestations of Lyme dis-ease. Arch Neurol 46: 790, 1989.PubMedGoogle Scholar
  118. 118.
    Mandell H, Steere AC, Reinhardt BN, Yoshinari N, Munsat TL, Brod SA, Clapshaw PA: Lack of antibodies to Borrelia burgdorferi in patients with amyotrophic lateral sclerosis [Letter]. N Engl J Med 320: 255, 1989.PubMedGoogle Scholar
  119. 119.
    Lesser RL, Kornmehl EW, Pachner AR, Kattah J, Hedges TR, Newman NM, Ecker PA, Glassman MI: Neuroophthalmologic manifestations of Lyme disease. Ophthalmo-logy 97: 699, 1990.Google Scholar
  120. 120.
    Farris BK, Webb RM: Lyme disease and optic neuritis. J Clin Neurol Ophthalmol 8: 73, 1988.Google Scholar
  121. 121.
    Finkel MF: Lyme disease and its neurologic complications. Arch Neurol 45: 99, 1988.PubMedGoogle Scholar
  122. 122.
    Wu G, Lincoff H, Ellsworth RM, Haik BG: Optic disc edema and Lyme disease. Ann Oph-thalmol 18: 252, 1986.Google Scholar
  123. 123.
    Schechter SL: Lyme disease associated with optic neuropathy. Am J Med 81: 143, 1986.PubMedGoogle Scholar
  124. 124.
    Bialasiewicz AA, Ruprecht KW, Naumann GOH, Blenk H: Bilateral diffuse choroiditis and exudative retinal detachments with evi-dence of Lyme disease. Am J Ophthalmol 105: 419, 1988.PubMedGoogle Scholar
  125. 125.
    Damrow T, Freedman H, Lane R, Preston KL: Is Ixodes (Ixodiopsis) angustus a vector of Lyme disease in Washington State? West J Med 150: 580, 1989.PubMedGoogle Scholar
  126. 126.
    Bruhn FW: Lyme disease. Am J Dis Child 138: 467, 1984.Google Scholar
  127. 127.
    Baum J, Barza M, Weinstein P, Groden J, Aswad M: Bilateral keratitis as a manifestation of Lyme disease. Am J Ophthalmol 105: 75, 1988.PubMedGoogle Scholar
  128. 128.
    Steere AC, Malawista SE, Bartenhagen NH, Spieler PN, Newman JH, Rahn AW, Hutch-inson GJ, Green J, Snydman DR, Taylor E: The clinical spectrum and treatment of Lyme disease. Yale J Biol Med 57: 453, 1984.PubMedGoogle Scholar
  129. 129.
    Bertuch AW, Rocco E, Schwartz EG: Lyme disease: ocular manifestations. Ann Oph-thalmol 20: 376, 1988.Google Scholar
  130. 130.
    Orlin SE, Lauffer JL: Lyme disease keratitis. Am J Ophthalmol 107: 678, 1989.PubMedGoogle Scholar
  131. 131.
    Kornmehl EW, Lesser RL, Jaros P, Rocco E, Steere AC: Bilateral keratitis in Lyme disease. Ophthalmology 96: 1194, 1989.PubMedGoogle Scholar
  132. 132.
    Flach AJ, Lavoie PE: Episcleritis, conjunc-tivitis, and keratitis as ocular manifestations of Lyme disease. Ophthalmology 97: 973, 1990.PubMedGoogle Scholar
  133. 133.
    Zaidman GW: Episcleritis and symblepharon associated with Lyme disease. Am J Oph-thalmol 109: 487, 1990.Google Scholar
  134. 134.
    Pavan-Langston D: Manual of Ocular Diag-nosis and Therapy, 2rd ed. Little, Brown, Boston, 1991.Google Scholar
  135. 135.
    Jones BR, Al-Hussaini KM, Dunlop EC: In-fection by trie agent and other menbers of the Bedsonia group, with a note on Reiter’s dis-ease. Trans Ophthalmol Soc UK 86: 291, 1966.PubMedGoogle Scholar
  136. 136.
    Gordon MA: Aerobic pathogenic Acti-nomycetaceae. In Lennette EH, Balows A, Hausler WJ, Shadomy HJ (Eds): Manual of Clinical Microbiology, 4th ed. American Soci-ety for Microbiology, Washington DC, 1985, pp 249–262.Google Scholar
  137. 137.
    Rifkind D, Marchioro TL, Schneck SA, Hill RB Jr: Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Am J Med 43: 28, 1967.PubMedGoogle Scholar
  138. 138.
    Young LS, Armstrong D, Blevins A, Lieber-man P: Nocardia asteroides infection compli-cating neoplastic disease. Am J Med 50: 356, 1971.PubMedGoogle Scholar
  139. 139.
    Francois J, Pysselaere M: Oculomycosis. Charles C Thomas, Springfield, IL, 1972.Google Scholar
  140. 140.
    Burpee JC, Strarke WR: Bilateral metastatic intraocular nocardiosis. Arch Ophthalmol 86: 666, 1971.PubMedGoogle Scholar
  141. 141.
    Jampol LM, Strauch BS, Albert DM: Intra-ocular nocardiosis. Am J Ophthalmol 76: 568, 1973.PubMedGoogle Scholar
  142. 142.
    Panijayanond P, Olsson CA, Spivack ML, Schmitt GW, Idelson BA, Sachs BJ, Mabseth DC: Intraocular nocardiosis in a renal trans-plant patient. Arch Surg 104: 845, 1972.PubMedGoogle Scholar
  143. 143.
    Kattan HM, Pflugfelder SC: Nocardia scleritis. Am J Ophthalmol 110: 446, 1990.PubMedGoogle Scholar
  144. 144.
    Davidson S, Foerster HC: Intraocular no-cardial abscess, endogenous. Trans Am Acad Ophthalmol Otolaryngol 71: 847, 1967.PubMedGoogle Scholar
  145. 145.
    Meyer SL, Font RL, Shaver RP: Intraocular nocardiosis: report of three cases. Arch Oph-thalmol 83: 536, 1970.Google Scholar
  146. 146.
    Hoeprich PD, Brandt D, Parker RH: Nocardial brain abscess cured with cycloserine and sulf-onamides. Am J Med Sci 255: 208, 1968.PubMedGoogle Scholar
  147. 147.
    Stenson S, Brookner A, Rosenthal S: Bilateral endogenous necrotizing scleritis due to Asper-gillus oryzae. Ann Ophthalmol 14: 67, 1982.PubMedGoogle Scholar
  148. 148.
    Margo CE, Polack FM, Mood CI: Aspergillus panophthalmitis complicating treatment of pterygium. Cornea 7: 285, 1988.PubMedGoogle Scholar
  149. 149.
    Lincoff HA, McLean JM, Nano H: Scleral abscess. I. A complication of retinal detach-ment buckling procedures. Arch Ophthalmol 74: 641, 1965.PubMedGoogle Scholar
  150. 150.
    Milauskas AT, Duke JR: Mycotic scleral ab-scess: report of a case following a scleral buck-ling operation for retinal detachment. Am J Ophthalmol 63: 951, 1967.PubMedGoogle Scholar
  151. 151.
    Slomovic AR, Forster RK, Gelender H: Hasiodiplodia theobromae panophthalmitis. Can J Ophthalmol 20: 225, 1985.PubMedGoogle Scholar
  152. 152.
    Kollner H: Schimmelpilzerkrankung der Sklera. Z Augenheilk 16: 441, 1906.Google Scholar
  153. 153.
    Sporotrichose gommeuse disseminee, gomme intra-oculaire, perforation de la sclerotique. Ann d’Oculistique, 148: 321, 1912.Google Scholar
  154. 154.
    Kuriakose ET: Oculosporidiosis. Rhinosporidi osis of the eye. Br J Ophthalmol 47: 346, 1963.PubMedGoogle Scholar
  155. 155.
    Lamba PA, Shucka KN, Ganapathy M: Rhinosporidium granuloma of the conjunctiva with scleral ectasia. Br J Ophthalmol 54: 565, 1970.PubMedGoogle Scholar
  156. 156.
    De Doncker RML, de Keizer RJW, Oosterhuis JA: Scleral melting in a patient with conjunc-tival rhinosporidiosis. Br J Ophthalmol 74: 635, 1990.PubMedGoogle Scholar
  157. 157.
    Hope-Simpson R: The nature of herpes zoster: a long-term study and a new hypothesis. Proc Soc Exp Biol Med 58: 9, 1965.Google Scholar
  158. 158.
    Weller T: Varicella and herpes zoster: changing concepts of the natural history, control, and importance of not so benign virus (part 1). N Engl J Med 309: 1362, 1983.PubMedGoogle Scholar
  159. 159.
    Dolin R, Reichman RC, Mazur MH, Whitley RJ: NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med 89: 375, 1978.PubMedGoogle Scholar
  160. 160.
    Gershon AA, Steinberg SP: Antibody re-sponses to varicella-zoster virus and the role of antibody in host defense. Am J Med Sci 282: 12, 1981.PubMedGoogle Scholar
  161. 161.
    Straus SE, Ostrove JM, Inchauspe G, Felser JM, Freifeld A, Croen KD, Sawyer MH: NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and pre-vention. Ann Intern Med 108: 221, 1988.PubMedGoogle Scholar
  162. 162.
    Weller T: Varicella and herpes zoster (part 2). N Engl J Med 309: 1434, 1983.PubMedGoogle Scholar
  163. 163.
    Kurland L: Descriptive epidemiology of se-lected neurological and myopathic disorders with particular reference to a survey in Rochester, Minnesota. J Chronic Dis 8: 378, 1958.PubMedGoogle Scholar
  164. 164.
    Ragozzino M: Population based study of herpes zoster and its sequelae. Medicine 61: 310, 1982.PubMedGoogle Scholar
  165. 165.
    Mahalingam R, Wellish M, Wolf W, Dueland AN, Cohrs R, Vafai A, Gilden D: Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med 323:627Google Scholar
  166. 166.
    Hyman RW, Ecker JR, Tenser RB: Varicella-zoster virus RNA in human trigeminal ganglia. Lancet 2: 814, 1983.PubMedGoogle Scholar
  167. 167.
    Liesegang TJ: Corneal complications from herpes zoster ophthalmicus. Ophthalmology 92: 316, 1985.PubMedGoogle Scholar
  168. 168.
    Harding SP, Lipton JR, Wells JCD: Natural history of herpes zoster ophthalmicus: pre-dictors of postherpetic neuralgia and ocular involvement. Br J Ophthalmol 71: 353, 1987.PubMedGoogle Scholar
  169. 169.
    Scheie HG: Herpes zoster ophthalmicus. Trans Ophthalmol Soc UK 90: 899, 1970.PubMedGoogle Scholar
  170. 170.
    Pavan-Langston D: Varicella-zoster ophthal-micus. Int Ophthalmol Clin 15 (4): 171, 1975.PubMedGoogle Scholar
  171. 171.
    Liesegang T: The varicella zoster virus: sys-temic and ocular features. J Am Acad Dermatol 11: 165, 1984.PubMedGoogle Scholar
  172. 172.
    Womack LW, Liesegang TJ: Complications of herpes zoster ophthalmicus. Arch Ophthalmol 101: 42, 1983.PubMedGoogle Scholar
  173. 173.
    Tuft SJ, Watson PG: Progression of scleral disease. Ophthalmology 98: 467, 1991.PubMedGoogle Scholar
  174. 174.
    Lyne AJ, Pitkeathley DA: Episcleritis and scleritis. Arch Ophthalmol 80: 171, 1968.PubMedGoogle Scholar
  175. 175.
    Liesegang TJ: Diagnosis and therapy of herpes zoster ophthalmicus. Ophthalmology 98:1216Google Scholar
  176. 176.
    Penman GG: Scleritis as a sequel of herpes ophthalmicus. Br J Ophthalmol 15: 585, 1931.PubMedGoogle Scholar
  177. 177.
    Levy R, Lobstein A: Une complication rare du zona ophthalmique; l’atrophie sclerale avec perforation. Bull Soc Ophthalmol Fr 3: 256, 1952.Google Scholar
  178. 178.
    Adelung JC: Skleralstaphylom nach Herpes zoster ophthalmicus. Klin Monatsbl Augen-heilk 118: 620, 1951.Google Scholar
  179. 179.
    Arducci F, Capelli I: Scleral staphyloma after scleritis caused by herpes zoster. Annal Ottalmologia 94: 187, 1968.Google Scholar
  180. 180.
    Solomon AR: New diagnostic tests for herpes simplex and varicella-zoster infections. J Am Acad Dermatol 18: 218, 1988.PubMedGoogle Scholar
  181. 181.
    Koneman EW, Allen SD, Dowell VR Jr, etal.: Color Atlas and Textbook of Diagnostic Micro-biology. Lippincott, Philadelphia, 1988, pp 691–764.Google Scholar
  182. 182.
    Solomon AR, Rasmussen RE, Weiss JS: A comparison of the Tzanck smear and viral isolation in varicella and herpes zoster. Arch Dermatol 122: 282, 1986.PubMedGoogle Scholar
  183. 183.
    Schwartz JN, Cashwell F, Hawkins HK, Klint-worth GK: Necrotizing retinopathy with herpes zoster ophthalmicus: a light and electron microscopical study. Arch Pathol Lab Med 100: 386, 1976.PubMedGoogle Scholar
  184. 184.
    Witmer R, Iwamoto T: Electron microscope observation of herpes-like particles in the iris. Arch Ophthalmol 79:331, 1968; and Witmer R: Personal communication, 1980.Google Scholar
  185. 185.
    Drew WL, Mintz L: Rapid diagnosis of varicella-zoster virus infection by direct im-munofluorescence. Am J Clin Pathol 73: 699, 1980.PubMedGoogle Scholar
  186. 186.
    Folkers E, Vreeswijk J, Oranje AP, Duiven-voorden JN: Rapid diagnosis in varicella and herpes zoster: re-evaluation of direct smears (Tzanck test) and electron microscopy includ-ing colloidal gold immuno-electron micros-copy in comparison with virus isolation. Br J Dermatol 121: 287, 1989.PubMedGoogle Scholar
  187. 187.
    Frey HM, Steinberg SP, Gershon AA: Rapid diagnosis of varicella-zoster virus infections by countercurrent immunoelectrophoresis. J Infect Dis 143: 274, 1981.PubMedGoogle Scholar
  188. 188.
    Richman DD, Cleveland PH, Redfield DC, Oxman MN, Wahl GM: Rapid viral diagnosis. J Infect Dis 149: 298, 1984.PubMedGoogle Scholar
  189. 189.
    Schmidt NJ: Varicella-zoster virus. In Lennette EH, Balows A, Hausler WJ Jr, Shadomy HJ (Eds): Manual of Clinical Microbiology, 4th ed. American Society for Microbiology, Washington DC, 1985, pp 720–727.Google Scholar
  190. 190.
    Harper DR, Grose C: IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and sub-clinical infectios, and vaccination. J Infect Dis 159: 444, 1989.PubMedGoogle Scholar
  191. 191.
    Cobo LM, Foulks GN, Lyesegang T, Lass J, Sutphin JE, Wilhelmus K, Jones DB, Chapman S, Segreti AC, King DH: Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology 93: 763, 1986.PubMedGoogle Scholar
  192. 192.
    Cobo LM: Reduction of the ocular compli-cations of herpes zoster ophthalmicus by oral acyclovir. Am J Med 85 (Suppl 2A): 90, 1988.PubMedGoogle Scholar
  193. 193.
    Zaal MJW, Maudga PC, Rietveld E, Suir EPE: Chronic ocular zoster. Current Eye Res 10 (suppl): 125, 1991.Google Scholar
  194. 194.
    Tilson HH: Monitoring the safety of antivirals. The example of the acyclovir experience. Am J Med 85 (Suppl 2A): 116, 1988.PubMedGoogle Scholar
  195. 195.
    Keczkes K, Basheer A: Do corticosteroids prevent postherpetic neuralgia? Br J Dermatol 102: 551, 1980.PubMedGoogle Scholar
  196. 196.
    Post BT, Philbrick JT: Do corticosteroids pre-vent postherpetic neuralgia? A review of the evidence. J Am Acad Derm 18: 605, 1988.PubMedGoogle Scholar
  197. 197.
    Esman V, Kroon S, Peterslund NA, Ronne- Rasmussen JO, Geil JP, Fogh H, Petersen CS, Danielsen L: Prednisolone does not prevent post-herpetic neuralgia. Lancet 2: 126, 1987.Google Scholar
  198. 198.
    Bernstein JE, Bickers DR, Dahl NV: Treat-ment of chronic postherpetic neuralgia with topical capsaicin. A preliminary report. J Am Acad Dermatol 17: 93, 1987.PubMedGoogle Scholar
  199. 199.
    Bucci FA Jr, Gabriels CF, Krohel GB: Suc-cessful treatment of postherpetic neuralgia with capsaicin. Am J Ophthalmol 106: 758, 1988.PubMedGoogle Scholar
  200. 200.
    Watson PN, Evans RJ: Postherpetic neuralgia. A review. Arch Neurol 43: 836, 1986.PubMedGoogle Scholar
  201. 201.
    Walsh TD: Antidepressants in chronic pain. Clin Neuropharmacol 6: 271, 1983.PubMedGoogle Scholar
  202. 202.
    Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH: Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 38: 1427, 1988.PubMedGoogle Scholar
  203. 203.
    Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J: Amitriptyline versus placebo in postherpetic neuralgia. Neurology 32: 671, 1982.PubMedGoogle Scholar
  204. 204.
    Scott T: Epidemiology of herpetic infection. Am J Ophthalmol 43: 134, 1957.PubMedGoogle Scholar
  205. 205.
    Lehner T, Wilton J, Shillitoe E: Immunological basis for latency, recurrences, and putative oncogenicity of herpes simplex virus. Lancet 2: 60, 1975.PubMedGoogle Scholar
  206. 206.
    Kaufman HE, Rayfield MA: Viral conjunc-tivitis and keratitis. In Kaufman HE, Barron BA, McDonald MB, Waltman SR (Eds): The Cornea. Churchill Livingstone, New York, 1988, pp 299–331.Google Scholar
  207. 207.
    Sainz de la Maza M, Wells PA, Foster CS: Cyclic nucleotide modulation of herpes simplex virus latency and reactivation. Invest Oph-thalmol Vis Sci 30: 2154, 1989.Google Scholar
  208. 208.
    Lam MT, Pazin GJ, Armstrong JA, Ho M: Herpes simplex infection in acute myelogenous leukemia and other hematologic malignancies. Cancer 48: 2168, 1981.PubMedGoogle Scholar
  209. 209.
    Leming PD, Martin SE, Zwelling LA: Atypical herpes simplex infection in a patient with Hodgkin’s disease. Cancer 54: 3043, 1984.PubMedGoogle Scholar
  210. 210.
    Centifanto-Fitzgerald YM, Yamaguchi T, Kaufman HE, Toghon M, Roizman B: Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA. J Exp Med 155: 475, 1982.PubMedGoogle Scholar
  211. 211.
    Gerdes JC, Smith DS: Recurrence phenotypes and establishment of latency following rabbit keratitis produced by multiple herpes simplex virus strains. J Gen Virol 64: 2441, 1983.PubMedGoogle Scholar
  212. 212.
    Sanitato JJ, Asbell PA, Varnell ED, Kissling GE, Kaufman HE: Acyclovir in the treatment of herpetic stromal disease. Am J Ophthalmol 98: 537, 1984.PubMedGoogle Scholar
  213. 213.
    Panzardi D: Contributo alia conoscenza delle lesioni erpetishe oculari: su di un particolare caso di compromissiono della conjunctiva, cornea ed episclera da virus erpetico. Bolletino d’Oculistica 26: 465, 1947.Google Scholar
  214. 214.
    Saba V: Sullo episcleriti erpetishe: contributo clinico. Annal Ottalmol Clin Oculistica 73: 168, 1947.Google Scholar
  215. 215.
    Sanna M: Episclerite erpetica. Bolletino d’Oculistica 29: 173, 1950.Google Scholar
  216. 216.
    La Lau C, Oosterhuis JA, Versteeg J, van Rij G, Renardel de Lavalette JG, Craandijk A, Lamers WR, Mierlobensteyn T: Acyclovir and trifluorothymidine in herpetic keratitis. Pre-liminary report of a multicentered trial. Doc Ophthalmol 50: 287, 1981.PubMedGoogle Scholar
  217. 217.
    La Lau C, Oosterhuis JA, Versteeg J, van Rij G, Renardel de Lavalette JG, Craandijk A, Lamers WR, Mierlobensteyn T: Multicenter trial of acyclovir and trifluorothymidine in herpetic keratitis. Am JMed73(lA): 305, 1982.Google Scholar
  218. 218.
    Pavan Langston D: Systemic acyclovir in her-pes simplex keratitis. Personal communication. New England Ophthalmological Society Meet-ing, September 13, 1991.Google Scholar
  219. 219.
    Foster CS, Barney NP: Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis. Doc Ophthalmol 80 (4): 363, 1992.PubMedGoogle Scholar
  220. 220.
    Meyer RF, Sullivan JH, Oh JO: Mumps con-junctivitis. Am J Ophthalmol 78: 1022, 1974.PubMedGoogle Scholar
  221. 221.
    Berg F: Scleritis pericornealis nach Parotitis epidemica. Berichte uber die Versammlungen der deutschen ophthalmologischen. Gesel-lschaft 46: 368, 1927.Google Scholar
  222. 222.
    Rieger M: Uber subconjunctivitis epibulbaris metastatica bei Parotitis epidemica. Archiv Ophthalmologic, 133: 505, 1935.Google Scholar
  223. 223.
    North DP: Ocular complications of mumps. Br J Ophthalmol 37: 99, 1953.PubMedGoogle Scholar
  224. 224.
    Swan KC, Penn RF: Scleritis following mumps. Report of a case. Am J Ophthalmol 53: 366, 1962.PubMedGoogle Scholar
  225. 225.
    Berger ST, Mondino BJ, Hoft RH, Donzis PB, Holland GN, Farley MK, Levenson JE: Suc-cessful medical management of Acanthamoeba keratitis. Am J Ophthalmol 110: 395, 1990.PubMedGoogle Scholar
  226. 226.
    Lindquist TD, Fritsche TR, Grutzmacher RD: Scleral ectasia secondary to Acanthamoeba keratitis. Cornea 9: 74, 1990.PubMedGoogle Scholar
  227. 227.
    Mannis MJ, Tamaru R, Roth AM: Acan-thamoeba sclerokeratitis. Determining diag-nostic criteria. Arch Ophthalmol 104: 1313, 1986.PubMedGoogle Scholar
  228. 228.
    Sterh-Green JK, Bailey TM, Visversvara GS: The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol 107: 331, 1989.Google Scholar
  229. 229.
    Chang PCT, Soong HK: Acanthamoeba kera-titis in non-contact lens wearers. Arch Oph-thalmol 109: 463, 1991.Google Scholar
  230. 230.
    Sharma S, Srinivasan M, George C: Acan-thamoeba keratitis in non-contact lens wearers. Arch Ophthalmol 108: 676, 1990.PubMedGoogle Scholar
  231. 231.
    Theodore FH, Jakobiec FA, Juechter KB, Pearl M, Troutman RC, Pang PM, Iwamoto T: The diagnostic value of a ring infiltrate in Acanthamoeba keratitis. Ophthalmology 92: 1471, 1985.PubMedGoogle Scholar
  232. 232.
    Moore MB, McCulley JP, Kaufman HE, Robin JB: Radial keratoneuritis as a presenting sign in Acanthamoeba keratitis. Ophthalmology 93: 1310, 1986.PubMedGoogle Scholar
  233. 233.
    Wilhelmus KR, Osato MS, Font RL, Robinson NM, Jones DB: Rapid diagnosis of Acan-thamoeba keratitis using calcofluor white. Arch Ophthalmol 104: 1309, 1986.PubMedGoogle Scholar
  234. 234.
    Marines HM, Osato MS, Font RL: The value of calcofluor white in the diagnosis of mycotic and Acanthamoeba infections of the eye and ocular adnexa. Ophthalmology 94: 23, 1987.PubMedGoogle Scholar
  235. 235.
    Epstein RJ, Wilson LA, Visvesvara GS: Rapid diagnosis of Acanthamoeba keratitis from cor-neal scrapings using indirect fluorescent anti-body staining. Arch Ophthalmol 104: 1318, 1986.PubMedGoogle Scholar
  236. 236.
    Hoft RH, Mondino BJ: The diagnosis and clinical management of Acanthamoeba kera-titis. Semin Ophthalmol 6: 106, 1991.Google Scholar
  237. 237.
    Ishibashi Y, Matsumoto Y, Kabata T: Oral itraconazol and topical miconazol with debride-ment for Acanthamoeba keratitis. Am J Oph-thalmol 109: 121, 1990.Google Scholar
  238. 238.
    Wilder HC: Toxocara chorioretinitis in adults. Arch Ophthalmol 48: 127, 1952.Google Scholar
  239. 239.
    Zimmerman LE: Ocular pathology of toxo-plasmosis. Surv Ophthalmol 6: 832, 1961.Google Scholar
  240. 240.
    Tokuda H, Okamura R, Kamano H: A case of brawny scleritis caused by Toxoplasma gondii. Rinsho Ganka 24: 565, 1970.Google Scholar
  241. 241.
    Schuman JS, Weinberg RS, Ferry AP, Guerry RK: Toxoplasmic scleritis. Ophthalmology 95: 1399, 1988.PubMedGoogle Scholar
  242. 242.
    Raistrick ER, Hart JCD: Ocular toxocariasis in adults. Br J Ophthalmol 60: 365, 1976.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • C. Stephen Foster
    • 1
  • Maite Sainz de la Maza
    • 2
  1. 1.Harvard Medical School, Immunology and Uveitis ServiceMassachusetts Eye and Ear InfirmaryBostonUSA
  2. 2.Central University of BarcelonaBarcelonaSpain

Personalised recommendations